GENERAL ATLANTIC L P
Q4 2023 Form 13-F

NEW YORK, NEW YORK
CIK 0001017645 · CRD 133536 · SEC-registered investment adviser
$7.0B Reported Value Total

GENERAL ATLANTIC SERVICE COMPANY, L.P. reports 141 total accounts under management (AUM). There are 141 discretionary accounts valued at $85,091,746,390, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
429 funds · $125.1B gross asset value
Private Equity Fund: $121.3B · Other: $3.7B · Real Estate Fund: $115.3M · Hedge Fund: $515.9K
Source: Form ADV filed 2026-08-12
Reported value
$7.0B
Quarter over quarter
+16.3%
Holdings
26
Top-10 concentration
91.7%

Key People

Form ADV owners & control persons
Gabriel Pierre Caillaux
CO-PRESIDENT AND MANAGING DIRECTOR OF GASC AND MEMBER OF THE PARTNERSHIP AND EXECUTIVE COMMITTEES OF GASC MGP
Martin Emiliano Escobari Lifchitz
CO-PRESIDENT AND MANAGING DIRECTOR OF GASC AND MEMBER OF THE PARTNERSHIP AND EXECUTIVE COMMITTEES OF GASC MGP
William Edward Ford
CHAIRMAN, CEO AND MANAGING DIRECTOR OF GASC AND MEMBER OF THE PARTNERSHIP AND EXECUTIVE COMMITTEES OF GASC MGP

Filing Navigation

13F Metrics

Loading 13F Metrics

Q4 2023 13F record

Q4 2023 13F filing summary

Q4 2023 Form 13F portfolio summary
Period of report December 31, 2023
Filed February 13, 2024
Form 13F-HR
Reported value $7.0B
Positions 26
Change in reported value +7.6%
New positions 0
Exited positions 3
Position turnover 10.3%
Top-10 concentration 91.7%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 13, 2026
12 $2.5B
Q2 2026 13F
Filed Aug 14, 2026
12 $2.9B
Q1 2026 13F
Filed May 15, 2026
12 $2.1B
Q4 2025 13F
Filed Feb 17, 2026
13 $2.9B
Q3 2025 13F
Filed Nov 13, 2025
16 $3.3B
Q2 2025 13F
Filed Aug 14, 2025
15 $3.6B
Q1 2025 13F
Filed May 14, 2025
15 $3.0B
Q4 2024 13F
Filed Feb 7, 2025
16 $2.8B
Q3 2024 13F
Filed Nov 12, 2024
18 $3.5B
Q2 2024 13F
Filed Aug 14, 2024
19 $3.2B
Q1 2024 13F
Filed May 15, 2024
22 $4.3B
Q4 2023 13F
Filed Feb 13, 2024
26 $7.0B
Q3 2023 13F
Filed Nov 14, 2023
29 $6.5B
Q2 2023 13F
Filed Aug 11, 2023
30 $6.3B
Q1 2023 13F
Filed May 15, 2023
31 $8.6B
Q4 2022 13F
Filed Feb 14, 2023
33 $7.6B
Q3 2022 13F
Filed Nov 14, 2022
39 $8.5B
Q2 2022 13F
Filed Aug 12, 2022
38 $7.7B
Q1 2022 13F
Filed May 16, 2022
35 $10.9B
Q4 2021 13F
Filed Feb 11, 2022
32 $13.0B

34 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q4 2023

Largest Q4 2023 13F positions by reported value
# Holding Reported value % of portfolio
1 ESMT ENGAGESMART $2.1B 29.66%
2 DLO DLOCAL $1.1B 16.22%
3 XP XP, INC $772.1M 11.08%
4 ALHC ALIGNMENT HEALTHCARE $525.2M 7.53%
5 ALKT ALKAMI $454.2M 6.52%
6 HRT HIRERIGHT $431.9M 6.2%
7 SQSP SQUARESPACE $350.3M 5.03%
8 KRTX KARUNA THERAPEUTICS $312.3M 4.48%
9 EWCZ EUROPEAN WAX CENTER $178.2M 2.56%
10 PHVS PHARVARIS $172.7M 2.48%
11 CNTA CENTESSA PHARMACEUTICALS $77.1M 1.11%
12 HCM HUTCHMED $72.4M 1.04%
13 IMCR IMMUNOCORE $64.9M 0.93%
14 MBLY MOBILEYE $57.1M 0.82%
15 BLND BLEND LABS $48.8M 0.7%
16 RPRX ROYALTY PHARMA $42.1M 0.6%
17 YOU CLEAR SECURE $41.9M 0.6%
18 AKRO AKERO THERAPEUTICS $41.7M 0.6%
19 THRD THIRD HARMONIC BIO $32.5M 0.47%
20 OPEN OPENDOOR $28.3M 0.41%

Values as reported on the Q4 2023 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings